This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Early Winners & Losers

PXRE Group (PXT) shot up more than 12% in extended trading Wednesday as the Bermuda-based reinsurance company announced it will merge with insurance underwriter Argonaut (AGII - Get Report). The planned stock swap will create a new company called Argo Group International, of which roughly 27% will be owned by former PXRE shareholders. Former Argonaut holders will own the rest.

PXRE separately reported narrowing losses on plummeting revenue in the fourth quarter. Its shares were surging 55 cents to $5.01 in recent after-hours action. Argonaut stock was up 35 cents, or 1%, to $34.50.

PDI (PDII) shares jumped after the business-services firm swung to a fourth-quarter profit of $4.8 million, or 35 cents a share, compared with a year-ago loss of 83 cents a share. The Saddle River, N.J., company's revenue sank 29% year over year to $55.8 million, but this beats two analysts' estimates by $7.2 million, according to Thomson Financial. Shares were trading up $1.63, or 16.5%, to $11.50.

Spectranetics (SPNC - Get Report) gained on strong preliminary results from a study of its Turbo-Booster device, which is proposed to help treat blockages in the main artery above the knee. The Food and Drug Administration decided, jointly with Spectranetics, that the study should end early in order that it be submitted for regulatory review. The trial had begun in July. Shares of the Colorado-based company were climbing 62 cents, or 6.3%, to $10.50, in recent after-hours trading.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AGII $57.97 1.15%
HIBB $35.11 -0.14%
PDII $0.42 5.09%
SPNC $17.95 -1.32%
WAVX $0.02 -61.10%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs